PEG ratio 2.27
PE ratio 56.80
Earnings next quarter 2 cents.
That's my 2 cents worth.
Two consecutive acquisitions accretive to earnings bringing next year's p/e ratio to about 13.25.
Valeant paid $8.7 billion in cash for Bausch & Lomb, the eye care and scientific instrument company Fischer Scientific.
VRX market cap is now $9.21 billion.
Almost there if you consider the pharmaceuticals business worthless.